2009
DOI: 10.1016/j.ejmech.2009.04.049
|View full text |Cite
|
Sign up to set email alerts
|

Diamine-based human histamine H3 receptor antagonists: (4-Aminobutyn-1-yl)benzylamines

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
4
0

Year Published

2010
2010
2022
2022

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 12 publications
(4 citation statements)
references
References 27 publications
0
4
0
Order By: Relevance
“…For example, the substitution of the piperidine ring with a morpholine in a series of (4aminobutyn-1-yl)benzylamines H 3 antagonists results in the improvement of potency and CNS druggability, as shown by JNJ-10181457 possessing a shorter plasma half-life and a higher ability to penetrate the BBB, with brain concentration values that roughly parallel those found in plasma (Figure 6). 62 Similarly, morpholine is contained in different mGlu2 (metabotropic Glutamate receptor 2) negative allosteric modulators (NAM) to increase their pharmacokinetic properties. mGlu2 is another metabotropic receptor that is broadly expressed in the CNS and represents an important therapeutic target for mood disorders (anxiety, depression, schizophrenia, addiction), as well as for neurodegenerative diseases such as Alzheimer's disease (AD) and Parkinson's disease (PD).…”
Section: ■ Biological Activity Of Morpholine Derivatives In Mood Diso...mentioning
confidence: 99%
“…For example, the substitution of the piperidine ring with a morpholine in a series of (4aminobutyn-1-yl)benzylamines H 3 antagonists results in the improvement of potency and CNS druggability, as shown by JNJ-10181457 possessing a shorter plasma half-life and a higher ability to penetrate the BBB, with brain concentration values that roughly parallel those found in plasma (Figure 6). 62 Similarly, morpholine is contained in different mGlu2 (metabotropic Glutamate receptor 2) negative allosteric modulators (NAM) to increase their pharmacokinetic properties. mGlu2 is another metabotropic receptor that is broadly expressed in the CNS and represents an important therapeutic target for mood disorders (anxiety, depression, schizophrenia, addiction), as well as for neurodegenerative diseases such as Alzheimer's disease (AD) and Parkinson's disease (PD).…”
Section: ■ Biological Activity Of Morpholine Derivatives In Mood Diso...mentioning
confidence: 99%
“…In an attempt to increase its affinity but also to reduce the undesired high brain residence time of 103 , Johnson & Johnson developed JNJ‐10181457 ( 104 ) which possesses high affinity ( K i = 1.2 nM) and more than 10 000 fold selectivity for H 3 over H 1 and H 4 . In the SAR studies that were conducted, meta‐substitution of the central phenyl ring provided the most potent antagonists, while various substituents proved to be more potent than the morpholine substituent of 104 .…”
Section: Pharmacological Activity Of Morpholine Derivatives On Varioumentioning
confidence: 99%
“…To demonstrate the synthetic utility of the TH of pyridinium salts, a gram-scale synthesis of 4a , an intermediate for the synthesis of paroxetine 17 and strychnocarpine derivatives, 18 was performed (Scheme 3). Furthermore, 4r and 4s , the key intermediates for the synthesis of HDAC inhibitor 7 19 and histamine H 3 receptor 8 , 20 respectively, were obtained in good yields under the standard reaction conditions.…”
mentioning
confidence: 96%